324 filings
Page 4 of 17
8-K
dq3w7j7
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
8-K
0g6r1
6 Oct 21
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
12:00am
8-K
s4ult uivo1qd
30 Sep 21
Skye Bioscience Announces Closing of $7.0 Million Registered Direct Offering
12:00am
8-K
wvs ygsfn
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
424B5
5ozkioo617j4xv
28 Sep 21
Prospectus supplement for primary offering
8:30am
8-K
f7cc1vgyx3pvp
15 Sep 21
Departure of Directors or Certain Officers
12:00am
EFFECT
otul5r3qc734 13
10 Aug 21
Notice of effectiveness
12:15am
424B3
7wt9hf82
5 Aug 21
Prospectus supplement
9:43pm
CORRESP
v7ztolmdy z7r0uxl
5 Aug 21
Correspondence with SEC
12:00am
UPLOAD
j2nwws3izcceos17vo0
4 Aug 21
Letter from SEC
12:00am
S-3
ggonno05giatei4
29 Jul 21
Shelf registration
12:00am
8-K
kl0ev
26 Jul 21
Skye Bioscience Appoints Biotech Executive
12:40pm
8-K
v1s9vd
22 Jul 21
Entry into a Material Definitive Agreement
8:00am
424B3
9mr 1fw71
7 May 21
Prospectus supplement
8:03am
424B3
8hyirb6k 9t
2 Mar 21
Prospectus supplement
12:00am
8-K
g5p9i3
3 Feb 21
Submission of Matters to a Vote of Security Holders
5:16pm